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Abstract
Authentic induced pluripotent stem cells (iPSCs), capable of giving rise to all cell types of an adult animal, are currently only
available in mouse. Here, we report the first generation of bovine iPSC-like cells following transfection with a novel virus-
free poly-promoter vector. This vector contains the bovine cDNAs for OCT4, SOX2, KLF4 and c-MYC, each controlled by its
own independent promoter. Bovine fibroblasts were cultured without feeders in a chemically defined medium containing
leukaemia inhibitory factor (LIF) and inhibitors of MEK1/2 and glycogen synthase kinase-3 signaling (‘2i’). Non-invasive real-
time kinetic profiling revealed a different response of bovine vs human and mouse cells to culture in 2i/LIF. In bovine, 2i was
necessary and sufficient to induce the appearance of tightly packed alkaline phosphatase-positive iPSC-like colonies. These
colonies formed in the absence of DNA synthesis and did not expand after passaging. Following transfection, non-
proliferative primary colonies expressed discriminatory markers of pluripotency, including endogenous iPSC factors, CDH1,
DPPA3, NANOG, SOCS3, ZFP42, telomerase activity, Tra-1-60/81 and SSEA-3/4, but not SSEA-1. This indicates that they had
initiated a self-sustaining pluripotency programme. Bovine iPSC-like cells maintained a normal karyotype and differentiated
into derivatives of all three germ layers in vitro and in teratomas. Our study demonstrates that conversion into induced
pluripotency can occur in quiescent cells, following a previously undescribed route of direct cell reprogramming. This
identifies a major species-specific barrier for generating iPSCs and provides a chemically defined screening platform for
factors that induce proliferation and maintain pluripotency of embryo-derived pluripotent stem cells in livestock.
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Introduction
Pluripotent stem cells (PSCs) are capable of unlimited
proliferation in vitro and generation of all adult cell types,
including functional gametes. They are either derived from a
transient cell population in the inner cell mass of pre-implantation
blastocysts (embryonic stem cells or ESCs) [1,2] or from post-natal
testis [3]. More recently, PSC-like cells were also derived from
post-implantation egg cylinder embryos [4,5]. These epiblast stem
cells (EpiSCs) express the core transcriptional pluripotency
network [6,7,8] and are capable of multi-lineage differentiation
[4,5]. However, ESCs and EpiSCs represent discrete pluripotent
states, termed ‘naı ¨ve’ and ‘primed’, respectively [9]. In contrast to
naı ¨ve ESCs, primed EpiSCs show flattened rather than packed
dome morphology. They have predominantly undergone X-
chromosome inactivation in female cells, up-regulated certain
specification markers (e.g. Fgf5, Lefty2, T or T-brachyury) and
down-regulated others that distinguish them from ESCs (e.g.
Dppa3 or Stella, Zfp42 or Rex1, Nr0b1, Klf2, Stat3, Lifr, Stat3 and
Socs3) [10,11,12].
Functionally, EpiSCs are poised to differentiate into primordial
germ cells in vitro and neither contribute to all somatic cell
lineages nor the germline in chimeras [13]. Under chemically
defined conditions, murine ESCs will self-renew or differentiate,
respectively, in response to leukemia inhibitory factor (LIF) and
fibroblast growth factor (FGF)/extracellular signal-regulated
kinase (ERK)-signaling [14]. In contrast, EpiSCs do not respond
productively to LIF and can be stably propagated in the presence
of FGF and activin [4]. Upon FGF/activin withdrawal and ectopic
expression of either Klf2, Klf4 [10], Nanog [15] or Nr5a [16],
EpiSCs can robustly revert to naı ¨ve ‘ground state’ pluripotency.
Delivering ectopic pluripotency-inducing genes into somatic
cells has become an established route of generating fully
pluripotent cells (induced pluripotent stem cells or iPSCs) by
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logical, molecular and functional criteria [18,19,20,21,22].
Completely reprogrammed iPSCs show mRNA and microRNA
expression patterns that are highly similar to isogenic ESCs [23].
DNA demethylation of the Oct4 (or Pou5f1) and Nanog promoter
regions and global patterns of histone methylation are virtually
indistinguishable from ESCs [19,21,22,24,25]. Functionally,
genuine iPSCs contribute to the germline in chimeric mice
[22,26,27] and support the development of embryos entirely
derived from iPSCs [28,29,30]. These functional assays have
become the most stringent criteria to define naı ¨ve pluripotency
[31].
Somatic cells from mouse [17], rat [32,33], pig [34,35], sheep
[36], horse [37], rabbit [38], monkey [39,40], and human [41]
have been reprogrammed using different factor combinations,
including OCT4 (O), SOX2 (S), KLF4 (K), c-MYC (M), LIN28,
NANOG [41] or Nr5a2 replacing OCT4 [42]. Factors are usually
delivered into cells by integrating viral vectors [18,41,43], but
integration-free reprogramming has also been achieved
[44,45,46,47,48,49]. To stabilize signaling pathways that maintain
pluripotency, culture media can be supplemented with small
molecules that alleviate differentiation cues. Ying et al. cultured
murine ESCs in medium that relies on the double inhibition (‘2i’)
of mitogen-activated protein kinase kinase (MAP2K1/2 or
MEK1/2) by PD0325901 and glycogen synthase kinase 3 beta
(GSK3B) by CHIR9902, respectively, to effectively promote
pluripotency [14]. Together with the self-renewal cytokine LIF,
which directly improves reprogramming efficiency [12], 2i/LIF
medium enabled the conversion of mouse EpiSCs into ESCs [10]
and from partially into fully reprogrammed iPSCs [50]. It also led
to the first derivation of bona fide ESCs from rat embryos [51,52].
Notably, application of 2i/LIF helps establishing a naı ¨ve or ‘mouse
ESC-like’ pluripotent state in human embryonic stem cells and
human iPSCs [11].
Over the past three decades, it has been difficult to derive PSCs
from other mammalian species and all attempts to derive chimera-
competent bovine PSCs have failed [53,54]. Here we explore the
possibility that 2i/LIF promotes pluripotency in cattle, a species
previously considered non-permissive for PSC-derivation [50].
Results
Bovine iPSC-like colonies form in 2i/LIF medium
In order to deliver all four factors into the same cell, we
constructed poly-promoter plasmids containing the complete
bovine cDNAs for OCT4, SOX2, KLF4, and c-MYC (Fig. 1A, B).
We first optimized several parameters for inducing pluripotency.
Eight different cell lines (embryonic [1 line] vs fetal [4 lines] vs
adult [2 lines] fibroblasts vs follicular cells [1 line]) were transfected
(lipofection vs nucleofection) with two different plasmids (pOSKM
vs pKMOS). SOX2, OCT4, and KLF4 showed appropriate
nuclear localization after transient transfection (Fig. 1C). Follow-
ing passaging and re-plating after 48 h, SOX2 immunostaining
showed that embryonic and fetal fibroblasts transfected most
efficiently (16% and 26%, respectively, Fig. 1D). Lipofection was
generally superior with no significant differences between the two
plasmids (data not shown). We then passaged lipofected cells onto
laminin-coated plates and replaced the somatic with 2i/LIF
medium (Fig. 1E). Dome-shaped, tightly packed colonies with
clear borders started to appear around 10 days post-transfection
and continued to increase in size and number thereafter (Fig. 1F).
With the exception of BFF-MBP, all cell lines gave rise to colonies
(Fig. 1F). Transfection efficiency correlated well with colony
formation (r
2=0.9591). We observed no significant differences
between the two plasmids and only a small number of BEF40-
derived colonies after nucleofection (data not shown). Since BEF40
resulted in the highest yield of colonies, we concentrated on this
line for subsequent experiments.
Following transduction, 2i/LIF medium has been shown to
promote reprogramming into naı ¨ve pluripotency in both mouse
and human iPSCs [11,50]. We therefore cultured mock- or
pOSKM-transfected cells in N2B27 supplemented with or without
LIF, PD or CHIR. PD applied alone or in combination with
CHIR and LIF greatly decreased phospho-MEK1/2 levels, while
total MEK1/2 protein was not affected (Fig. S1). CHIR alone did
not modulate phospho-MEK1/2. BEF40 cultured in either N2B27
or N2B27/LIF retained the typical morphology of bovine
fibroblasts serum-starved into quiescence [55] (Fig. 2A). Addition
of PD or CHIR to non-transfected cells, either with or without
LIF, was sufficient to induce formation of colonies, of which
7764% were AP+ (Fig. 2A). These colonies were in size,
morphology and AP staining intensity indistinguishable from
transfected colonies cultured under the same conditions (Fig. 2A).
The average area and number of nuclei per AP+ colony on D16,
determined from confocal sections of Hoechst-stained samples
(n=14), was 4742962839 mm
2 and 156621, respectively. iPSC-
like cell nuclei were significantly smaller than their ancestral
BEF40 nuclei (2364 mm
2 vs 131615 mm
2,P ,0.001). The
number of CHIR-induced AP+ single cells and colonies was
higher than for non-supplemented N2B27 or PD alone but not
significantly different from cells treated with PD/CHIR or PD/
CHIR + pOSKM (Fig. 2B). PD also induced AP+ colonies but this
was not significant (P=0.20) compared to non-supplemented
medium. Culture in 2i/LIF was necessary to induce AP activity, as
pOSKM-transfected BEF40 in N2B27 did not give rise to AP+
colonies. When we cultured non-transfected murine embryonic or
human skin fibroblasts in LIF, PD, and CHIR, alone or in
combination, we saw no morphological transformation into
colonies or AP induction (n=4 independent experiments).
Overall, we transfected 2.35610
4 cells/cm
2 with a transfection
efficiency of approximately 16% (=3.76610
3 transfectants/cm
2)
and obtained about 15 AP+ colonies/cm
2, resulting in a
reprogramming efficiency of 0.4%.
To better characterize the response of bovine vs comparable
murine and human cell types to 2i/LIF, we conducted non-
invasive kinetic cell profiling using the xCELLigence
TM. This
integrated real-time system displays changes in cell proliferation,
viability, morphology and adhesion as CI values. In bovine,
addition of LIF, PD, or PD/LIF had no significant effect
compared to non-treated controls. After normalization on LIF-
treated controls, both CHIR and PD/CHIR significantly reduced
the CI in different bovine cell types (Fig. 2C). In contrast, PD,
CHIR and PD/CHIR all significantly increased the CI in both
murine and human fibroblasts (Fig. 2C).
Bovine iPSC-like colonies do not expand in 2i/LIF
Next we investigated the mechanism of bovine iPSC-like colony
formation. As a proxy for cell proliferation, we quantified DNA-
synthesis following different EdU-incorporation protocols. Only
AP+ colonies were quantified (Fig. 3A). EdU was added to each
transfected culture on D0, 2, 4, 6, 8, 10, 12 or 14 following the
addition of 2i/LIF and cells fixed 48 h after labelling (‘pulse-fix’,
Fig. 3B). When the first colonies become visible, only 561% of
cells still synthesized DNA and this further declined to 260.6%
after two weeks in culture. To determine what proportion of EdU-
incorporating nuclei became part of iPSC-like colonies, cells were
labelled every two days (‘pulse’), washed out of EdU (‘chase’) and
further cultured until fixation on D16 (‘pulse-chase’, Fig. 3B). After
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each colony ended up being labelled with EdU on D16. When
pulsed around the time of colony formation (D8), only 862% of
cells within each colony still synthesized DNA. This proportion
further declined to 262% after two weeks in culture, closely
matching results from pulse-fix experiments. In order to detect
slowly cycling cells, cultures were continuously kept in EdU until
fixation at D16 (‘cumulative label’, Fig. 3B). This demonstrated that
most cells in colonies (8160.02%) were cycling at least once during
the culture period. However, during the time of primary colony
formation only 10% of cells within each colony still synthesized
DNA and, in agreement with the pulse-label experiments, colonies
labelled towards the end of the culture period (.D12) contained less
than 5% proliferating cells. Cumulatively labelled non-transfected
control cells, cultured in either 2i/LIF or N2B27, also became non-
proliferative over time (Fig. S2A). This indicates that culture
conditions, not plasmid-induced reprogramming, induced quies-
cence. Using immunofluorescence, we further quantified the
proportion of cells expressing cell proliferation markers Ki-67 and
proliferating cell nuclear antigen (PCNA) in pKMOS-transfected
BEF40 cells (Fig. S2B) and colonies (Fig. S2C). For both antigens,
the proportion of positive cells progressively declined over time (Fig.
S2D). Using the Click-iT EdU assay, the proportion of apoptotic
cells in primary colonies was small (,5% of total nuclei), indicating
that most bovine iPSC-like cells in 2i/LIF were neither proliferating
nor apoptotic but quiescent (Fig. S2E). Taken together, these results
suggest that colonies primarily formed from non-proliferating cells
and did not expand further through cell division.
Once colonies had formed, we determined whether their growth
was influenced by the culture substrate. Colonies were manually
picked and plated on feeder cells or laminin. Individual colonies
were tracked for two weeks and their area was determined at
regular intervals (Fig. 3C). All tracked colonies stained AP+ at the
end of the tracking period. On both substrates there was no
significant increase in colony area (n=13 and n=4 for feeders vs
laminin, respectively). Regression splines plotted for each colony
and colony averages showed no significant differences in shape
(P=0.2), indicating that colony growth was not differentially
affected by substrate composition.
In order to establish bovine iPSC lines, we passaged colonies
using either accutase or microblade dissociation. Initial plating
efficiency was high (20/22=91% vs 22/22=100%, respectively).
After first passaging, colonies growing on laminin were tracked for
65 days and their area determined (Fig. 3D). Tracked colonies
stained AP+ at the end of the tracking period. In all cases (n=5
and n=12 for accutase vs blade, respectively), colony area
significantly declined over time (P,0.001). Regression splines
plotted for each colony and colony averages showed no significant
differences in shape (P=0.13), indicating that colony growth was
not differentially affected by the passaging regime. In summary,
colonies that formed from quiescent cells in 2i/LIF showed no
signs of expansion for extended periods of time after passaging.
Bovine iPSC-like colonies express discriminatory markers
of pluripotency
We then evaluated molecular markers of pluripotency. Cultur-
ing BEF40 in somatic medium or 2i/LIF did not induce detectable
expression of pluripotency-associated transcription factors
(Fig. 4A). In contrast, pKMOS-transfected BEF40 in 2i/LIF
induced NANOG, SALL4 and DPPA3, while markers of primed
EpiSCs (FGF5, LEFTY2, T-BRACHYURY) were not detectable
(Fig. 4A). Using primers that distinguished between endogenous
(Fig. S3A) and ectopic iPSC factors (Fig. S3B), we determined that
one day post-transfection most SOX2, OCT4 and KLF4 transcripts
were of ectopic origin (99.7%, 99.9% and 88%, respectively),
whilst in primary colonies (18 days post-transfection), most
transcripts were transcribed from endogenous loci (99.9%,
56.7% and 78.5%, respectively, Fig. 4B). Using plasmid-specific
primers, we detected presence of the transgene in genomic DNA
of D38 colonies, indicating stable integration of the vector (Fig.
S3C). Telomerase activity, evident by a ladder of products with 6
base increments, was high in bovine iPSC-like cells and mouse
ESCs used as a positive control (Fig. 4C). Neither non- or mock-
transfected BEF40 in 2i/LIF, nor pKMOS-transfected BEF40
without 2i/LIF showed detectable telomerase activity. Confocal
immunofluorescence analysis showed that iPSC-like cells ex-
pressed the pluripotency surface markers SSEA-3/4 and TRA-1-
60/81, but not SSEA-1 (Fig. 4D). They also expressed OCT4 and
SOX2 (Fig. S4). None of these markers were detected in non-
transfected BEF40 in 2i/LIF (data not shown). Taken together,
these data show that bovine iPSC-like colonies displayed several
discriminatory markers of pluripotency.
Bovine iPSC-like colonies differentiate in vitro and in
teratomas
Bovine iPSC-like colonies formed solid and cystic EBs after 5
days to 3 weeks, respectively, in N2B27 suspension culture
(Fig. 5A). These expressed ectoderm- (TUBB3, GFAP, NES),
endoderm- (AFP) and mesoderm- (GATA4, MEF2C) markers
(Fig. 5B). Following injection of iPSC-like cells from two
independent tranfections into SCID mice, large tissue masses,
ranging from 8–20 mm in diameter and 1–5 g in weight, were
harvested after seven weeks from two out of four hind legs.
Histological examination of the two specimens showed differen-
tiation into ectoderm (epidermis, neural tissue), endoderm (ciliated
epithelium) and mesoderm (bone, cartilage) (Fig. 5C). These
features were consistent with intramuscular grade 3 teratomas.
Bovine-specific primers detected ACTB in both genomic DNA
(Fig. S5A) and reverse transcribed cDNA (Fig. S5B) from bovine
iPSC-, but not murine ESC-derived, teratomas. This confirms that
the tumor originated from bovine cells. We conclude that iPSC-
like cells are capable of multi-lineage differentiation and
production of complex teratomas. Lastly, we karyotyped bovine
iPSC-like cells after 24 days in culture and all cells (n=12/12)
showed a normal number of 60 chromosomes (Fig. 5D).
Discussion
Here we report the first reprogramming of non-proliferating
bovine cells into pluripotency under conditions of chemically
defined signal inhibition. We refer to these cells as ‘‘iPSC-like’’
because their capacity for germline chimerism remains to be
demonstrated. The first iPSC reports used integrating viruses to
carry the pluripotency genes into cells, potentially disrupting
Figure 1. Generating bovine iPSC-like cells. (A, B) Maps of poly-promoter constructs used in this study; (C) Immunofluorescence 24 h post-
transfection with pOSKM. DNA was counterstained with Hoechst 33342. OCT4 and SOX2 co-localized in nuclei (arrowheads), circled cells stained
negative; (D) Transfection efficiency; bars with different superscripts differ P,0.05 for lipofection (
abc), nucleofection (
xyz) or across groups (*, **); (E)
Timeline of iPSC generation using lipofection. (F) iPSC-like colonies appear after pOSKM lipofection. Insert: AP+ BEF40-derived colonies (arrowheads),
18 days post-transfection. Scale bar =100 mm.
doi:10.1371/journal.pone.0024501.g001
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Episomal viruses reduce the risk of insertional mutagenesis during
iPSC generation [45,57,58]. However, viral DNA may still trigger
the immune system [59]. This raises biosafety concerns for
agricultural applications where the products (e.g. meat, milk) of
iPSC-derived farm animals or their offspring ultimately enter the
human food chain. Our constructs avoid lentiviral backbones or
foot-and-mouth disease virus 2A oligopeptides [46,60,61] that in
many countries would not be permissive for commercial livestock
applications. Instead, we used single transfection of a novel
expression vector where each bovine iPS factor was flanked by its
own independent CMV promoter. Since our work in bovine
started, iPSCs in other species have been produced using plasmid-
mediated approaches. This either involved serial co-transfection of
two plasmids containing different sets of factors [44,46,49] or
transfection of a polycistronic vector transcribing several factors
from a single promoter [44,49,61]. In some cases, transfection
approaches have resulted in iPSCs with no evidence of transgene
integration [46,61]. As primary bovine iPSC-like colonies were
likely of mixed origin, i.e. derived from more than a single
reprogrammed fibroblast, and generation of clonal cell lines was
unsuccessful, we did not attempt to identify non-integrative iPSC
clones. Presence of the transgene in genomic DNA of D38 colonies
indicated that at least some cells had stably integrated the vector.
Compared to virus-mediated delivery methods, plasmids are
technically simple and relatively cheap, eliminating the need for
specialized biohazard containment facilities to produce viral stocks
[21]. Overall, bovine reprogramming efficiency, corrected for
transfection efficiency, was 0.4%. This was consistent with virus-
and plasmid-mediated approaches (ranging from 0–8% and
averaging 1% [44,46,48,62]). It remains to be determined if the
new poly-promoter design and use of isogenic bovine sequences
results in higher reprogramming efficiency of bovine cells than
using alternative vector designs carrying homologous mouse or
human iPS genes.
Following transduction, 2i medium promotes reprogramming
into naı ¨ve pluripotency by neutralizing inductive differentiation
stimuli in both mouse and human iPSCs [11,50]. This effect
appeared even more pronounced in bovine cells. CHIR and, to a
lesser extent, PD induced colony formation and AP activity in
bovine, but not murine or human, fibroblasts. How these two
compounds elicit the transformation from single cells to compact-
ed colonies, including changes in cell shape and size, migration
and intercellular clustering, is not clear. It would be important to
better characterize the dependency of bovine cells on MEK,
GSK3B and components of their respective signaling pathways.
Likewise, the signaling cascade leading to AP induction in bovine
cells is not known. AP induction was unrelated to the
morphological and molecular changes that caused colony
formation, as it also occurred in single cells. High level of AP
expression is a fairly non-specific marker for PSCs [63] that
appears very early during the iPSC reprogramming [43]. More
stringent molecular markers of pluripotency, such as telomerase
activity, NANOG, and SALL4, were only induced when the cells
were transfected with iPS vectors in the presence of 2i/LIF. This
also applied to DPPA3, SOCS3 and ZFP42, all discriminatory
markers of naı ¨ve pluripotency [10]. Silencing ectopic gene
expression and activating endogenous iPS factors is considered
another hallmark of full reprogramming [64]. We observed that
SOX2, OCT4 and KLF4 transcripts predominantly originated from
the endogenous loci. This indicates progressive epigenetic silencing
of the CMV promoter, as previously described after transient
transfection of ESCs [65]. Cell surface antigens SSEA-3/4 and
TRA-1-60/81 also appear late during reprogramming and are
considered among the most definitive markers of fully repro-
grammed iPSCs [64]. Bovine iPSC-like cells strongly expressed
both marker sets, similar to undifferentiated iPSCs in pig [35],
monkey [39,40], and human [41] but different from mouse [17]
and rat [32,33] which express SSEA-1 instead. Lastly, diagnostic
markers of human embryo-derived stem cells and rodent EpiSCs
(FGF5, T-BRACHYURY, and LEFTY2) were not detectable in 2i/
LIF-cultured bovine iPSC-like cells, providing additional molec-
ular evidence of reprogramming into pluripotency.
A molecular link between pluripotency and the capacity for
unlimited self-renewal is the presence of telomerase. This
ribonucleoprotein is specifically active in immortal cells, such as
cancer, germ cells and PSCs [66,67], stabilizing telomere length
and extending cellular life span [68]. Bovine iPSC-like cells
exhibited telomerase activity similar to mouse ESCs, suggesting
that they were poised for long-term proliferation. The formation of
large solid teratomas from a few thousand injected colonies
indicates that bovine iPSC-like colonies did not irreversibly lose
their proliferation potential in 2i/LIF and can resume cell division
in the right environment.
Under serum-free 2i/LIF conditions, ERK-reliant cell types
(e.g. MEFs) either die or become quiescent [50]. Murine and
human iPSCs, on the other hand, arise from rapid proliferation
[62,69,70]. In fact, it has been suggested that proliferation pro-
motes pluripotency induction, whereas cell cycle arrest inhibits
reprogramming and induces irreversible differentiation [70]. In
mouse and human, individual reprogrammed cells first start to
divide faster, getting smaller in the process and then giving rise to
primary colonies through symmetric cell divisions [62,69,70]. As
primary colonies expand, cells detach and form secondary colonies
elsewhere [62]. Consequently, the number of primary colonies
remains constant after some time, while the number of secondary
colonies continues to increase [62]. We also observed a reduction
in nucleus size as fibroblasts converted into iPSC-like cells, most
likely during the first few days in 2i/LIF when most cells were still
cycling. However, several lines of evidence suggest that prolifer-
ation was unlikely to play a major role during colony biogenesis: i)
95% of cells did not synthesize DNA when colonies formed (EdU
pulse-fix); ii) .90% of cells present in colonies on D16 were
outside S-phase one week earlier, around the time of colony
formation (EdU pulse-chase); iii) .90% of cells within the
population did not synthesize DNA during the week following
colony formation (EdU cumulative labelling); iv) the proportion of
Ki-67 and PCNA expressing cells decreased over time, correlating
well with the decline in EdU-incorporation; v) primary colonies
did not expand for several weeks before or after passaging; vi) the
number of primary colonies stabilized after some time with no
subsequent multiplication into secondary colonies. Irrespective of
the EdU labelling protocol, ,2% of cells still synthesized DNA in
D16 colonies. At that time, almost all cells within each colony were
Figure 2. 2i/LIF affects colony formation and AP induction. (A) AP+ colonies after no, empty vector (pCMVe) or pOSKM-transfection. Scale
bar=100 mm; (B) Quantification of AP+ iPSC-like colonies, 15 days after passaging BEF40;
ab treatments differ P,0.005 for colonies. (C) xCELLigence
TM
real-time kinetic profiling. Cell indices were determined for bovine and murine embryonic (BEF40, MEF, respectively), bovine fetal (BFF) and bovine,
murine and human adult fibroblasts (AESF, MLF, and BJ, respectively). Curves were normalized after compound addition (blue vertical line) and slopes
(red bars) determined during log phase (between blue and red vertical lines); *= slopes differ P,0.05 from LIF-treated control.
doi:10.1371/journal.pone.0024501.g002
Generation of Bovine iPSC-Like Cells in 2i Medium
PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24501Generation of Bovine iPSC-Like Cells in 2i Medium
PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24501non-apoptotic and positive for SSEA-3/4 and TRA-1-60/81,
providing direct evidence for the quiescence of molecularly
reprogrammed iPSC cells. The kinetic response of bovine
fibroblasts vs their murine and human counterparts was also
characterized using an xCELLigence
TM electronic cell sensor
array. Based on their reduced CI values, bovine cells significantly
diverged from mouse/human in their overall cell proliferation,
morphology, and/or adhesion response to PD and CHIR, but not
LIF, addition. This provides further evidence for previously
unidentified differences in signaling pathways between these
species. Varying PD and CHIR concentration may alleviate their
anti-proliferative effect, perhaps through minimizing side effects
on other kinases. Excluding cell proliferation as the main
mechanism of colony formation, bovine iPSC colonies in 2i/LIF
likely formed through migration and aggregation of individual
cells that had become quiescent before or during re-acquisition of
pluripotency. It is conceivable that quiescence may have even
enhanced cell reprogrammability, similar to its beneficial effect in
nuclear transfer-induced epigenetic reprogramming [71,72].
Several applications await bovine iPSC-like cells. First, they
provide a chemically defined screening platform for candidate
factors that maintain both proliferation and pluripotency of
pluripotent stem cells in livestock. This is particularly relevant for
establishing embryo-derived stem cells. Second, they may be
converted into animals by using them as donors for somatic
cloning with the prospect of significantly increasing cloning
efficiency compared to conventional donors [73,74]. Bovine
iPSC-like cells will also be tested for their ability to generate
germline chimeras. Since germline transmission of superior
genetics is the most important criterion for breeding, such animals
would serve the same purpose as clones. Third, the pluripotent cell
state facilitates transgenesis and homologous recombination
[75,76,77]. Provided their proliferation block can be overcome,
bovine iPSC-like cells would facilitate the precise genetic
engineering of farm animals for improved production traits and
biopharming. Beyond these agricultural applications, bovine
iPSC-like cells would help to provide large animal models for
human diseases [78,79,80,81,82,83,84], complementing research
currently carried out with laboratory animals.
Materials and Methods
Plasmid construction
Complete protein coding cDNA sequences of bovine OCT4,
SOX2, KLF4 and c-MYC were obtained from GeneBank (accession
numbers NM_174580, NM_001105463.1, BC134523, and
NM_001046074, respectively). After introducing silent mutations
in KLF4 (TCG to TCC at position 1398) and OCT4 (GGT to
GGA at position 967) and adding a 59- XhoI and 39-SalI site,
respectively, the altered sequences were synthesized (GENEART,
Germany). The CDS encoding a zinc finger nuclease was removed
from pRK5.GZF1-N and the plasmid ligated using a linker (Fw 59-
GGCTAGCTCGAGACGTG-39,R v5 9- GTCGACACGTCTC-
GAGCTAGCCGC-39) that added an XhoI site downstream of the
CMV promoter. The resulting plasmid was linearized with SacI,
and ligated using a linker (Fw 59- CCTAGGGTACCACGT-
GAGCT -39,R v5 9- CACGTGGTACCCTAGGAGCT-39) that
added a KpnI site upstream of CMV promoter (‘pCMVe-K).
Following XhoI and SalI digest, the four factors were each inserted
into pCMVe-K, resulting in single-factor plasmids (pO, pS, pK,
pM). pO and pK were digested with KpnI, and the fragment
containing both CMV promoter and vector sequence cloned into
KpnI-linearized pS and pM, respectively, resulting in double-factor
vectors (pKM, pSO). Both were partially digested with KpnIt o
isolate one fragment containing the vector, and one containing
the two transcription factors with their CMV promoter. The
fragments containing two factors were ligated into the linearized
plasmids containing the other two, resulting in four-factor vectors
(pOSKM, pKMOS). Plasmids were isolated using a PureLink
TM
HiPure Plasmid Filter Kit (Invitrogen).
Cell culture and plasmid transfection
Primary bovine cell lines were isolated as described [85,86]:
hypodermal fibroblasts from pooled day (D) 40 male and female
IVF embryos (‘BEF40’); fetal lung fibroblasts from a D64 female
fetus and its male sibling (‘BFF64’); clonal cell strains of transgenic
BFFs (‘BFF-MBP [87]’, ‘BFF-OCT4_GFP’ [88]); adult ear skin
fibroblasts from two different bulls (‘AESF-1’, ‘-801’); and adult
follicular cells (‘EFC’). Mouse lines were either derived from D13.5
embryos (‘MEF’) or adult lung tissue (‘MLF’). Human skin
fibroblasts (‘BJ’) were obtained from ATCCH (CRL-2522
TM). In
pilot experiments, mitomycin C-inactivated female D34 embry-
onic fibroblasts (‘BEF34’) served as feeders. Cells were seeded at
2.3561
4 cells/cm
2 and cultured in Dulbecco’s Modified Eagle
Medium: Nutrient Mixture F-12 (DMEM/F12, Gibco) with
Glutamax
TM-I, 10% fetal calf serum (FCS, Invitrogen). This
‘somatic medium’ was supplemented with 2 mM valproic acid
(VPA, Calbiochem). After seeding, cells were cultured for two days
in somatic medium/VPA before transfection with 1 mg DNA per
2610
5 cells using lipofection (Lipofectamine
TM LTX/PLUS
TM,
Invitrogen) or nucleofection (programme A-24, Lonza, Germany).
Two days post-transfection, lipofected cells were passaged onto 8-
well glass chambers (BD, USA) or tissue culture dishes coated for
1 h at 2–4 mg/cm
2 per tissue culture dish and 5–7 mg/cm
2 per
glass chamber with natural mouse laminin (Invitrogen). The next
day, they were shifted into iPS medium (‘2i/LIF’), comprising of
MEK1/2 inhibitor PD0325901 (0.4 mM, Stemgent, USA),
GSK3B inhibitor CHIR99021 (3 mM, Stemgent), and human
LIF (20 ng/ml, Genscript) in DMEM/F12 supplemented with N2
(Gibco) and mixed 1:1 with Neurobasal medium (Gibco)
supplemented with B27 (Gibco) and 1 mM L-glutamine
(‘N2B27’) [14]. Nucleofected cells were seeded onto laminin-
coated culture vessels in somatic medium/VPA and shifted into
2i/LIF N2B27 medium the following day. Culture medium was
changed every 3–4 days.
Colony tracking and size determination
Colonies were either passaged by mouth pipette-assisted
dissociation into large fragments in accutase
TM (Millipore, New
Zealand) or by cutting with a splitting blade (ESE 020, Bioniche
Animal Health, USA) mounted to a micromanipulator (MO-188,
Nikon Narishige, Japan). Fragments were cultured in 2i/LIF and
photographed at regular intervals. For size determination, bright-
Figure 3. Bovine iPSC-like colonies do not expand in 2i/LIF. (A) Primary AP+ colonies with EdU+ nuclei (arrowheads) after 24 h label. Scale bar
=50mm. (B) DNA-synthesis after EdU addition (solid blue horizontal lines). EdU+ nuclei were counted after fixation (solid blue vertical lines). Open
arrow indicates first emerging colonies. (C) Prior to passaging, colonies from feeders (black triangles) or laminin (green circles) were tracked.
Regression splines were plotted for each colony (left) and averages (right graph). (D) After accutase (black triangles) or blade (green circles)
passaging, colonies on laminin were tracked. Regression splines were plotted for each colony (left) and averages (right graph).
doi:10.1371/journal.pone.0024501.g003
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ij/) and areas measured using polygon selection.
Cell proliferation assays
Real-time changes in cell number, viability, and morphology
were quantified using an RTCA-SP xCELLigence
TM system
(Roche, New Zealand). For each treatment, cells were seeded in
triplicate in 100 ml somatic medium at 2.35610
4 cells/cm
2 onto
laminin-coated 96-well E-Plates. In pilot experiments, the peak cell
index (CI) for each cell line was determined. Each compound was
diluted in pre-warmed medium and added at 1/4 to 1/3 of the
peak CI, around 24 h after plating. CI readings were taken every
1 h. Curves were normalized on the respective CI values 30 min
after compound addition when temperature of the fresh medium
had equilibrated. Curve slope was determined during the interval
between normalization time point and plateau phase (log phase),
and normalized on the LIF-treated control.
DNA synthesis was assessed using a click-iTH EdU (5-ethynyl-
29-deoxyuridine) proliferation assay (Invitrogen). Cells were: fixed
with 4% paraformaldehyde (PFA) every two days (‘pulse-fix’);
washed out of EdU and cultured in medium supplemented with
10 mM thymidine quench (‘pulse-chase’); or kept in EdU
(‘cumulative’). Cells stained without EdU labelling served as a
negative control. In addition, we performed immunocytochemistry
against Ki-67 and PCNA as described below.
Detection of apoptosis
Apoptosis was examined with the click-iTH TUNEL Alexa
FluorH Imaging Assay (C10246; Invitrogen). Cells were fixed,
permeabilized and stained according to the manufacturer’s
Figure 5. Differentiation of bovine iPSC-like colonies in vitro and in teratomas. (A) Simple (arrowheads) and cystic (arrows) EBs. Scale bar
=50mm. (B) RT-PCR analysis of differentiation marker expression in cystic EBs. cDNA from bovine fetal brain (ectoderm), gut (endoderm) and heart
(mesoderm) provides a positive control. (C) Histological sections of intramuscular teratomas from different pools of colonies (#1, #2). (D) Karyotype
of bovine iPSC-like cells after 24 days in culture.
doi:10.1371/journal.pone.0024501.g005
Figure 4. Molecular characterization of bovine iPSC-like colonies. (A) RT-PCR analysis. cDNA was extracted from 10 colonies/pool, cDNA from
10 bovine blastocysts/pool (bovine D16 epiblasts and MII oocytes for T-BRACHYURY and FGF5, respectively) provides a positive control. (B) qRT-PCR of
endogenous vs total target gene expression in cells vs colonies (1 d vs 18 d post-transfection, respectively); target genes values were normalized on
18S expression. *= values differ P,0.05 between time points; (C) Telomerase activity using the TRAP assay. Heat-inactivated (+) samples and CHAPS
buffer serve as negative, mouse ESCs (v6.5) and 36 bp internal control band (arrow) as positive controls. (D) Confocal immunofluorescence. DNA was
counterstained with Hoechst 33342. Arrowheads indicate negative cells. Stainings without primary antibodies (anti-mouse 488 and anti-rat 568)
provide negative controls. Phase = phase contrast, DIC = Differential interference contrast. Scale bar =50 mm.
doi:10.1371/journal.pone.0024501.g004
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DNA and RNA isolation
For genomic DNA isolation, cells or 50–100 mg of finely
ground liquid nitrogen frozen tissue samples were lysed in
100 mM Tris pH 8, 200 mM NaCl, 5 mM EDTA, 0.1%
SDS and 1 mg/ml proteinase K at 55uC. After 12–18 hours,
samples were digested with RNAse A (10 mg/ml) at 37uCf o r
30 min, extracted twice with phenol/chloroform/isoamyl alcohol
(25:24:1) and ethanol-precipitated. The air-dried pellet was
resuspended in 50–100 mlH 2O and used for PCR. For RNA
isolation, cells or 50–100 mg of finely ground liquid nitrogen
frozen tissue samples were lysed in TRIZOLH (Invitrogen)and
cDNA synthesized as described [89]. Reverse transcriptase was
omitted in one sample, each time a batch was processed for
cDNA synthesis (‘-RT’).
PCR and RT-PCR
A Mastercycler Gradient (Eppendorf, Germany) or Thermal
cycler (Bio-Rad, New Zealand) was used for PCR amplification
using primers shown in Table S1. Ectopic forward primers bind at
different positions of vector-specific 59-UTR, between pCMV and
the first ATG of the insert (i.e. in pOSKM: pos. 618–711 for
OCT4, pos. 2637–2738 for SOX2, pos. 4544–4631 for KLF4 and
pos. 6902–6995 for c-MYC). Ectopic reverse primers bind in their
respective target gene. Endogenous primers span specifically
between in the 59-UTR (SOX2, OCT4)o r3 9-UTR (KLF4, c-
MYC) and the adjacent exon of their respective target gene. The
PCR was performed using the following conditions: one cycle
denaturation at 95uC for 5 minutes, followed by 35 cycles of 30
seconds at 95uC, 30 sec at 52–63uC (see Table S1 for primer-
specific annealing temperatures), 30 seconds at 72uC; 7 min
extension at 72uC and cooling to 4uC.
Real-Time RT-PCR
A LightCyclerH (Roche, New Zealand) was used for qPCR
amplification and data analysis. All reactions were performed with
the LightCyclerH FastStart DNA MasterPLUS SYBR Green I Kit.
Primers were designed using LightCyclerH Probe Design 2.0 or
NCBI/Primer-BLAST. The ready-to-use ‘‘Hot Start’’ Light-
CyclerH reaction mix consisted of 0.4 ul of each primer (10 mM),
2.0 ml LightCyclerH SYBR Green I master mix, 5.2 ml DEPC
water, 1.0 ml DMSO if required and 1–2.0 ml cDNA template.
The following four-segment program was used: 1) denaturation
(10 min at 95 uC); 2) amplification and quantification (20 sec at 95
uC, 20 sec at 52–63 uC, followed by 20 sec at 72 uC with a single
fluorescent measurement repeated 45 times); 3) melting curve (95
uC, then cooling to 65 uC for 20 sec, heating at 0.2 uC sec-1 to 95
uC while continuously measuring fluorescence); and 4) cooling to 4
uC. Product identity was confirmed by gel electrophoresis and
melting curve analysis. For relative quantification, external
standard curves were generated from serial 5-log dilutions for
each gene in duplicate. One high efficiency curve (3.6$ slope
$3.1, R
2.0.99) was saved for each target gene and imported for
relative quantification as described [89].
Alkaline phosphatase (AP) activity
C e l l sw e r ew a s h e dw i t hP B S T( 0 . 0 5 %T w e e n H 20 in PBS),
and fixed with 4% PFA for 2 min at room temperature. After
PBST washing, cells were stained in 1 ml NTMT buffer
( 1 0m M T r i s p H9 . 5 , 1 0 0m M N a C l , 5 0m M M g C l 2,1 %
TweenH 20) with 3.38 ml/ml of 100 mg/ml NBT reagent
(Roche) and 3.5 ml/ml of 50 mg/ml BCIP reagent (Roche) for
20 min in the dark. A commercial staining kit (Stemgent) was
used occasionally.
Immunoblotting
Western blot analyses were carried out using the following
antibodies: phospho(Thr202/Tyr204)-p44/42 MEK1/2 (#9101)
and p44/42 MEK1/2 (#9102, both Cell signalling). Whole cell
lysates (40 mg per lane) were resolved on 4–12% Bis-Tris SDS-
Page gradient NuPage gels, transferred to nitrocellulose mem-
branes and blotted for phospho-MEK1/2 and pMEK1/2 (both
1:1000). The secondary antibody, goat anti-rabbit IgG-HRP
(Dako, P0448), was used at 1:5000 and peroxidise activity was
visualized with Western Lightning Plus-ECL kit (PerkinElmer,
NEL105001EA).
Immunocytochemistry
The following antigens were analyzed: SOX2 (AF2018, R&D
Systems), OCT4 (sc-9081), SSEA-1 (sc-21702), SSEA-3 (sc-21703),
and SSEA-4 (sc-21704, all Santa Cruz), Ki-67 (ab15580), PCNA
(ab29), KLF4 (Ab72543), TRA-1-60 (Ab16288), and TRA-1-81
(Ab16289, all Abcam). Cells were fixed in 4% PFA for 15 min at
4uC, washed in PBS, quenched in 50 mM NH4Cl in PBS for
10 min, permeabilized in 0.1% (v/v) Triton X-100 in PBS for
10 min at room temperature and blocked in 5% donkey serum,
5% BSA in PBS for 30 min. Primary antibodies were incubated
overnight at 4uC, washed in PBS and incubated with Alexa FluorH
488 or 546 donkey anti-mouse, -rat, -rabbit or -goat secondary
IgG antibodies (all Invitrogen) for 30 min at 38.5uC. All antibodies
were diluted in blocking buffer. DNA was counterstained with
5 mg/ml Hoechst 33342 (Sigma). Preparations were washed in
PBS and once in H2O before mounting (DAKO, Med-Bio Ltd.,
New Zealand). Negative controls were processed the same way,
except that the primary antibodies were replaced with blocking
buffer. Images were taken on an epifluorescence (Olympus BX50)
or confocal microscope (Olympus FluoView FV1000).
Telomerase activity
Telomerase activity was determined with the TRAPEZEH kit
(Chemicon, USA). Heat-inactivated (85uC for 10 min) samples
were used as internal negative controls. Reactions were separated
on non-denaturing TBE-based 10% polyacrylamide (19:1) gels,
stained with SYBR Gold (Invitrogen) and visualized on a Gel
Doc
TM 2000 documentation system (Bio-Rad).
Karyotyping
Bovine iPSC-like colonies (D24 post-transfection) were
cultured for 2 days in 2i/LIF with 10% serum replacer
(Invitrogen), treated with 1.67 mM nocodazole (Sigma) over-
night, trypsinized and centrifuged at 1000 rpm for 5 min. The
pellet was resuspended in 0.56% KCl solution, incubated at
38uC for 15 min and fixed in 220uC methanol: acetic acid (3:1)
at 4uC for 30 min. Washing with fresh fixative was repeated
twice before re-suspending the pellet in 500 mlo fi c e - c o l d
fixative, spreading onto chilled microscope slides and staining
with 10% KaryoMAXH Giemsa in Gurr buffer, pH 6.8 (BDH,
New Zealand).
Embryoid body (EB) formation
Undifferentiated iPSC-like colonies were picked by mouth
pipette and cultured on bacterial-grade Petri dishes (Falcon, USA)
for 5–21 days in N2B27. The medium was changed every 2 days.
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On D24 post-transfection, cells and colonies were harvested
using a cell scraper, centrifuged and re-suspended in PBS +1%
PVA (10–30k). Using a 23G needle, 100 ml of cell suspension
(approximately 1–5610
6 cells per site) was injected intramuscu-
larly into the quadriceps of adult immune deficient (SCID) male
mice. After 5–7 weeks, tumors were graded [90], dissected, fixed
overnight in Davidson’s fixative, embedded in paraffin, sectioned,
haematoxylin–eosin stained and analyzed by a pathologist service
(Gribbles, New Zealand). Investigations complied with the New
Zealand Animal Welfare Act 1999 and were approved by the
Ruakura Animal Ethics Committee (AE Application 11849).
Statistical Analysis
All values are presented as mean 6 S.E.M, unless indicated
otherwise. Statistical significance was accepted at P,0.05 and
determined using the two-tailed t-test with equal variance (Fig. 1,
2, 4). Log ratios of the colony tracking data (Fig. 3) were analyzed
using the residual maximum likelihood method in GenStatH (12
th
Edition), with the treatments as fixed effects and individual
colonies as random effects.
Supporting Information
Figure S1 Immunoblot analyses of steady-state levels of
phospho(Thr202, Tyr204)-MEK1/2 and total MEK1/2 in
BEF40 after 24h in N2B27 with solvent control (DMSO),
PD at the indicated concentrations, 3 mM CHIR, 0.4 mM
PD plus 3 mM CHIR (2i) or 2i/LIF.
(TIF)
Figure S2 Proliferation and apoptosis in bovine fibro-
blasts and iPSC-like cells (A) Non-transfected BEF40
cells were cultured in 2i/LIF or N2B27. EdU+ nuclei were
counted after EdU addition (solid blue horizontal lines) and
fixation (solid blue vertical lines). BEF40 cells on D4 (B) and D18
(C) post-transfection with pKMOS were analyzed by immunoflu-
orescence. DNA was counterstained with Hoechst 33342. White
circles = positive PCNA/negative Ki-67; red circles = positive
PCNA/Ki-67; arrowheads = negative PCNA/Ki-67. (D) Positive
nuclei were counted at indicated time points. Open arrow
indicates first emerging colonies. (E) Apoptotic nuclei were
identified by Click-iT staining (arrows). DNA was counterstained
with Hoechst 33342. Omission of EdU and DNase-treatment of
cells provide negative and positive controls, respectively.
(TIF)
Figure S3 iPSC-like cells express endogenous and
ectopic iPS factors. RT-PCR using primers specific for
endogenous (A) and ectopic (B) OCT4, SOX2, KLF4 and c-MYC
mRNAs. cDNA was extracted from BEF40 one day post-
transfection or from 10 pooled iPSC-like colonies 18–20 days
post-transfection. cDNA from 50 bovine blastocysts/pool and
pKMOS DNA provide controls. (C) PCR using plasmid-specific
primers (c-MYC, KLF4). Genomic DNA was extracted from ,150
colonies on D38 post-transfection. pKMOS and BEF DNA
provide positive and negative controls; primers amplifying 18S
DNA serve as loading controls.
(TIF)
Figure S4 Molecular characterization of bovine iPSC-
like colonies by confocal immunofluorescence. DNA was
counterstained with Hoechst 33342. Arrowheads indicate positive
cells. Scale bar =50 mm.
(TIF)
Figure S5 PCR analysis of genomic DNA and RT-PCR
analysis of cDNA from bovine iPSC-like-derived terato-
mas. Mouse ESC-derived teratomas provide a negative control.
Species-specific primers amplify ACTB in bovine iPSC-derived
(#1), but not mESC-derived teratomas, confirming bovine origin
of tumour tissue. Primers amplifying both bovine and mouse 18S
DNA and cDNA provide a loading control.
(TIF)
Table S1 Primers used for end-point and/or quantita-
tive (q) real-time RT-PCR; *= includes 4% or 10%
DMSO for end-point or qPCR, respectively, ND = not
determined.
(DOC)
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